Last 12 months
Inside the activity.
0 purchase rows · 64 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 24 |
| Dec 2025 | 0 | 6 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 12 |
| Mar 2026 | 0 | 13 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 4 |
| Sep 2026 | 0 | 3 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 08, 2022 Filed Feb 10, 2022 12:53 UTC |
Mackin James PPresident & CEO
|
Exercise / conversionStockOption(RightTo Buy) · Derivative | 10,638 | $11.00 Strike: $11.00 | $117,018.00 |
DisclosureSEC source: 0000784199-22-000018 · certent-form4.xml · derivative · entry 3 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,277 Underlying: Common Stock · 10,638 shares Expires 2022-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 2/19/2016 Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 12:53 UTC |
Mackin James PPresident & CEO
|
SaleCommon Stock | 10,638 | $17.75 | $188,771.31 |
DisclosureSEC source: 0000784199-22-000018 · certent-form4.xml · nonDerivative · entry 2 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 304,178 F1 · shares: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on Sept 3, 2021 F2 · price: Reflects weighted average price. Range of prices were between $17.4 to $17.89. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 08, 2022 Filed Feb 10, 2022 12:53 UTC |
Mackin James PPresident & CEO
|
Exercise / conversionCommon Stock | 10,638 | $11.00 | $117,018.00 |
DisclosureSEC source: 0000784199-22-000018 · certent-form4.xml · nonDerivative · entry 1 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 314,816 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on Sept 3, 2021 Read SEC document |
| February 07, 2022 Filed Feb 8, 2022 21:38 UTC |
Mackin James PPresident & CEO
|
Exercise / conversionStockOption(Right To Buy) · Derivative | 10,638 | $11.00 Strike: $11.00 | $117,018.00 |
DisclosureSEC source: 0000784199-22-000016 · certent-form4.xml · derivative · entry 3 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,915 Underlying: Common Stock · 10,638 shares Expires 2022-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 2/19/2016 Read SEC document |
| February 07, 2022 Filed Feb 8, 2022 21:38 UTC |
Mackin James PPresident & CEO
|
SaleCommon Stock | 10,638 | $17.30 | $184,052.29 |
DisclosureSEC source: 0000784199-22-000016 · certent-form4.xml · nonDerivative · entry 2 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 304,178 F1 · shares: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on Sept 3, 2021 F2 · price: Reflects weighted average price. Range of prices were between $16.90 to $17.51. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 07, 2022 Filed Feb 8, 2022 21:38 UTC |
Mackin James PPresident & CEO
|
Exercise / conversionCommon Stock | 10,638 | $11.00 | $117,018.00 |
DisclosureSEC source: 0000784199-22-000016 · certent-form4.xml · nonDerivative · entry 1 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 314,816 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on Sept 3, 2021 Read SEC document |
| December 31, 2021 Filed Feb 11, 2022 00:49 UTC |
Maney Rochelle L.VP, Quality
|
GrantCommon Stock | 225 | $17.30 | $3,891.94 |
DisclosureSEC source: 0000784199-22-000028 · certent-form5.xml · nonDerivative · entry 2 Maney Rochelle L. · CIK 0001850597 · VP, Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,527 F1 · price: These shares were acquired pursuant to Artivion Inc.'s Employee Stock Purchase Plan (ESPP). The shares were acquired in transactions exempt pursuant to 16b-3 Read SEC document |
| December 31, 2021 Filed Feb 11, 2022 00:47 UTC |
Maier Dennis BVice President, Operations
|
GrantCommon Stock | 167 | $17.30 | $2,888.68 |
DisclosureSEC source: 0000784199-22-000026 · certent-form5.xml · nonDerivative · entry 2 Maier Dennis B · CIK 0001742150 · Vice President, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,989 F1 · price: These shares were acquired pursuant to Artivion Inc.'s Employee Stock Purchase Plan (ESPP). The shares were acquired in transactions exempt pursuant to 16b-3 Read SEC document |
| December 31, 2021 Filed Feb 11, 2022 00:45 UTC |
Holloway Jean FSVP, General Counsel
|
GrantCommon Stock | 318 | $17.30 | $5,500.61 |
DisclosureSEC source: 0000784199-22-000022 · certent-form5.xml · nonDerivative · entry 2 Holloway Jean F · CIK 0001540065 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,557 F1 · price: These shares were acquired pursuant to Artivion Inc.'s Employee Stock Purchase Plan (ESPP). The shares were acquired in transactions exempt pursuant to 16b-3 Read SEC document |
| December 27, 2021 Filed Feb 11, 2022 00:46 UTC |
LEE DAVID ASHLEYExecutive VP, COO & CFO
|
GiftCommon Stock | 17,560 | $20.82 | $365,599.20 |
DisclosureSEC source: 0000784199-22-000024 · certent-form5.xml · nonDerivative · entry 1 LEE DAVID ASHLEY · CIK 0001112830 · Executive VP, COO & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 275,125 F1 · shares: 17,560 shares were gifted by the reporting person. Read SEC document |
| December 09, 2021 Filed Dec 10, 2021 21:13 UTC |
Horton AmyVP, Chief Accounting Officer
|
GiftCommon Stock | 1,500 | $18.82 | $28,230.00 |
DisclosureSEC source: 0000784199-21-000217 · certent-form4.xml · nonDerivative · entry 2 Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,282 F2 · price: 1,500 shares were gifted by the reporting person to a charity. Read SEC document |
| December 08, 2021 Filed Dec 10, 2021 21:13 UTC |
Horton AmyVP, Chief Accounting Officer
|
SaleCommon Stock | 2,500 | $18.57 | $46,422.00 |
DisclosureSEC source: 0000784199-21-000217 · certent-form4.xml · nonDerivative · entry 1 Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,782 F1 · price: Reflects weighted average price. Range of prices were between $18.42 to $18.62. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| November 29, 2021 Filed Nov 30, 2021 21:40 UTC |
SEMEDO ANTHONY B.Director
|
PurchaseCommon Stock | 15,000 | $17.36 | $260,400.00 |
DisclosureSEC source: 0000784199-21-000213 · certent-form4.xml · nonDerivative · entry 2 SEMEDO ANTHONY B. · CIK 0001886324 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,992 F2 · shares: Reflects open market purchase by reporting person. Read SEC document |
| November 29, 2021 Filed Nov 30, 2021 21:40 UTC |
SEMEDO ANTHONY B.Director
|
GrantCommon Stock | 4,992 | $17.36 | $86,661.12 |
DisclosureSEC source: 0000784199-21-000213 · certent-form4.xml · nonDerivative · entry 1 SEMEDO ANTHONY B. · CIK 0001886324 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,992 F1 · shares: Represents shares of restricted stock that cliff vest on November 29, 2022, provided the status as a Director with CryoLife continues through such date. Read SEC document |
| November 29, 2021 Filed Dec 1, 2021 21:14 UTC |
Davis John ESenior VP, Global Sales
|
PurchaseCommon Stock | 600 | $17.33 | $10,398.00 |
DisclosureSEC source: 0000784199-21-000215 · certent-form4.xml · nonDerivative · entry 1 Davis John E · CIK 0001653206 · Senior VP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,499 F1 · shares: Reflects open market purchase by reporting person. Read SEC document |
| November 04, 2021 Filed Nov 5, 2021 20:30 UTC |
Maney Rochelle L.VP, Quality
|
Disposition to issuerCommon Stock | 214 | $21.21 | $4,538.94 |
DisclosureSEC source: 0000784199-21-000209 · certent-form4.xml · nonDerivative · entry 1 Maney Rochelle L. · CIK 0001850597 · VP, Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,108 F1 · shares: Represent shares of restricted stock that were withheld for taxes on the grant vest date. Read SEC document |
| August 31, 2021 Filed Sep 1, 2021 20:14 UTC |
Holloway Jean FSVP, General Counsel
|
SaleCommon Stock | 663 | $26.49 | $17,565.92 |
DisclosureSEC source: 0000784199-21-000196 · certent-form4.xml · nonDerivative · entry 1 Holloway Jean F · CIK 0001540065 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,567 F1 · price: Reflects weighted average price. Range of prices were between $26.46 to $26.506. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 30, 2021 Filed Aug 31, 2021 21:11 UTC |
MORGAN HARVEYDirector
|
GiftCommon Stock | 3,645 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-21-000194 · certent-form4.xml · nonDerivative · entry 2 MORGAN HARVEY · CIK 0001137972 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned indirectly by Spouse in a Revocable Trust Disclosed balance after: 46,342 Read SEC document |
| August 30, 2021 Filed Aug 31, 2021 21:11 UTC |
MORGAN HARVEYDirector
|
GiftCommon Stock | 3,645 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-21-000194 · certent-form4.xml · nonDerivative · entry 1 MORGAN HARVEY · CIK 0001137972 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,768 F1 · shares: 3,645 shares were gifted by the reporting person to a trust for the benefit of his spouse for no consideration. Read SEC document |
| August 25, 2021 Filed Aug 26, 2021 20:13 UTC |
McCall Ronald DDirector
|
SaleCommon Stock | 5,667 | $25.63 | $145,265.61 |
DisclosureSEC source: 0000784199-21-000192 · certent-form4.xml · nonDerivative · entry 1 McCall Ronald D · CIK 0001016766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,768 F1 · price: Reflects weighted average price. Range of prices were between $25.625 to $25.69. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 23, 2021 Filed Aug 24, 2021 21:15 UTC |
Maier Dennis BVice President, Operations
|
SaleCommon Stock | 2,715 | $25.64 | $69,613.14 |
DisclosureSEC source: 0000784199-21-000190 · certent-form4.xml · nonDerivative · entry 1 Maier Dennis B · CIK 0001742150 · Vice President, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,677 F1 · price: Reflects weighted average price. Range of prices were between $25.64 to $25.69. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 30, 2021 Filed Feb 11, 2022 00:49 UTC |
Maney Rochelle L.VP, Quality
|
GrantCommon Stock | 194 | $20.07 | $3,893.29 |
DisclosureSEC source: 0000784199-22-000028 · certent-form5.xml · nonDerivative · entry 1 Maney Rochelle L. · CIK 0001850597 · VP, Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,302 F1 · price: These shares were acquired pursuant to Artivion Inc.'s Employee Stock Purchase Plan (ESPP). The shares were acquired in transactions exempt pursuant to 16b-3 Read SEC document |
| June 30, 2021 Filed Feb 11, 2022 00:47 UTC |
Maier Dennis BVice President, Operations
|
GrantCommon Stock | 145 | $20.07 | $2,909.93 |
DisclosureSEC source: 0000784199-22-000026 · certent-form5.xml · nonDerivative · entry 1 Maier Dennis B · CIK 0001742150 · Vice President, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,822 F1 · price: These shares were acquired pursuant to Artivion Inc.'s Employee Stock Purchase Plan (ESPP). The shares were acquired in transactions exempt pursuant to 16b-3 Read SEC document |
| June 30, 2021 Filed Feb 11, 2022 00:45 UTC |
Holloway Jean FSVP, General Counsel
|
GrantCommon Stock | 672 | $20.07 | $13,486.03 |
DisclosureSEC source: 0000784199-22-000022 · certent-form5.xml · nonDerivative · entry 1 Holloway Jean F · CIK 0001540065 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,239 F1 · price: These shares were acquired pursuant to Artivion Inc.'s Employee Stock Purchase Plan (ESPP). The shares were acquired in transactions exempt pursuant to 16b-3 Read SEC document |
| June 30, 2021 Filed Feb 11, 2022 00:43 UTC |
Davis John ESenior VP, Global Sales
|
GrantCommon Stock | 1,058 | $20.07 | $21,232.47 |
DisclosureSEC source: 0000784199-22-000020 · certent-form5.xml · nonDerivative · entry 1 Davis John E · CIK 0001653206 · Senior VP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,557 F1 · price: These shares were acquired pursuant to Artivion Inc.'s Employee Stock Purchase Plan (ESPP). The shares were acquired in transactions exempt pursuant to 16b-3 Read SEC document |
| June 01, 2021 Filed Jun 2, 2021 20:28 UTC |
Salveson Jon WDirector
|
GrantCommon Stock | 4,423 | $29.39 | $129,991.97 |
DisclosureSEC source: 0000784199-21-000179 · certent-form4.xml · nonDerivative · entry 1 Salveson Jon W · CIK 0001372026 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,639 F1 · shares: Represents shares of restricted stock that cliff vest on June 1, 2022, provided the status as a Director with CryoLife continues through such date. Read SEC document |
| June 01, 2021 Filed Jun 2, 2021 20:26 UTC |
MORGAN HARVEYDirector
|
GrantCommon Stock | 4,423 | $29.39 | $129,991.97 |
DisclosureSEC source: 0000784199-21-000176 · certent-form4.xml · nonDerivative · entry 1 MORGAN HARVEY · CIK 0001137972 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,413 F1 · shares: Represents shares of restricted stock that cliff vest on June 1, 2022, provided the status as a Director with CryoLife continues through such date. Read SEC document |
| June 01, 2021 Filed Jun 2, 2021 20:25 UTC |
McCall Ronald DDirector
|
GrantCommon Stock | 4,423 | $29.39 | $129,991.97 |
DisclosureSEC source: 0000784199-21-000173 · certent-form4.xml · nonDerivative · entry 1 McCall Ronald D · CIK 0001016766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,435 F1 · shares: Represents shares of restricted stock that cliff vest on June 1, 2022, provided the status as a Director with CryoLife continues through such date. Read SEC document |
| June 01, 2021 Filed Jun 2, 2021 20:23 UTC |
Burbank Jeffrey HDirector
|
GrantCommon Stock | 4,423 | $29.39 | $129,991.97 |
DisclosureSEC source: 0000784199-21-000171 · certent-form4.xml · nonDerivative · entry 1 Burbank Jeffrey H · CIK 0001341411 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,595 F1 · shares: Represents shares of restricted stock that cliff vest on June 1, 2022, provided the status as a Director with CryoLife continues through such date. Read SEC document |
| June 01, 2021 Filed Jun 2, 2021 20:22 UTC |
Bullock JamesDirector
|
GrantCommon Stock | 4,423 | $29.39 | $129,991.97 |
DisclosureSEC source: 0000784199-21-000169 · certent-form4.xml · nonDerivative · entry 1 Bullock James · CIK 0001172340 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,446 F1 · shares: Represents shares of restricted stock that cliff vest on June 1, 2022, provided the status as a Director with CryoLife continues through such date. Read SEC document |
| June 01, 2021 Filed Jun 2, 2021 20:21 UTC |
Borgstrom Marna PDirector
|
GrantCommon Stock | 4,423 | $29.39 | $129,991.97 |
DisclosureSEC source: 0000784199-21-000167 · certent-form4.xml · nonDerivative · entry 1 Borgstrom Marna P · CIK 0001744267 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,887 F1 · shares: Represents shares of restricted stock that cliff vest on June 1, 2022, provided the status as a Director with CryoLife continues through such date. Read SEC document |
| June 01, 2021 Filed Jun 2, 2021 20:20 UTC |
BEVEVINO DANIEL JDirector
|
GrantCommon Stock | 4,423 | $29.39 | $129,991.97 |
DisclosureSEC source: 0000784199-21-000165 · certent-form4.xml · nonDerivative · entry 1 BEVEVINO DANIEL J · CIK 0001186458 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,860 F1 · shares: Represents shares of restricted stock that cliff vest on June 1, 2022, provided the status as a Director with CryoLife continues through such date. Read SEC document |
| June 01, 2021 Filed Jun 2, 2021 20:18 UTC |
ACKERMAN THOMAS FDirector
|
GrantCommon Stock | 4,423 | $29.39 | $129,991.97 |
DisclosureSEC source: 0000784199-21-000163 · certent-form4.xml · nonDerivative · entry 1 ACKERMAN THOMAS F · CIK 0001141720 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,695 F1 · shares: Represents shares of restricted stock that cliff vest on June 1, 2022, provided the status as a Director with CryoLife continues through such date. Read SEC document |
| May 25, 2021 Filed May 27, 2021 21:02 UTC |
Davis John ESenior VP, Global Sales
|
Exercise / conversionStock Options (Right To buy) · Derivative | 5,402 | $26.24 Strike: $26.24 | $141,748.48 |
DisclosureSEC source: 0000784199-21-000158 · certent-form4.xml · derivative · entry 5 Davis John E · CIK 0001653206 · Senior VP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,402 shares Expires 2027-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 2/19/2021 Read SEC document |
| May 25, 2021 Filed May 27, 2021 21:02 UTC |
Davis John ESenior VP, Global Sales
|
Exercise / conversionCommon Stock | 5,402 | $26.24 | $141,748.48 |
DisclosureSEC source: 0000784199-21-000158 · certent-form4.xml · nonDerivative · entry 4 Davis John E · CIK 0001653206 · Senior VP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,638 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 25, 2021 Filed May 27, 2021 21:02 UTC |
Davis John ESenior VP, Global Sales
|
SaleCommon Stock | 6,457 | $29.65 | $191,470.07 |
DisclosureSEC source: 0000784199-21-000158 · certent-form4.xml · nonDerivative · entry 3 Davis John E · CIK 0001653206 · Senior VP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,899 F3 · price: Reflects weighted average price. Range of prices were between $29.44 to $30.135. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 25, 2021 Filed May 27, 2021 21:02 UTC |
Davis John ESenior VP, Global Sales
|
SaleCommon Stock | 880 | $29.70 | $26,135.03 |
DisclosureSEC source: 0000784199-21-000158 · certent-form4.xml · nonDerivative · entry 2 Davis John E · CIK 0001653206 · Senior VP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,356 F2 · price: Reflects weighted average price. Range of prices were between $29.47 to $30.04. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 25, 2021 Filed May 27, 2021 21:02 UTC |
Davis John ESenior VP, Global Sales
|
SaleCommon Stock | 5,402 | $29.67 | $160,274.64 |
DisclosureSEC source: 0000784199-21-000158 · certent-form4.xml · nonDerivative · entry 1 Davis John E · CIK 0001653206 · Senior VP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,236 F1 · price: Reflects weighted average price. Range of prices were between $29.47 to $30.14. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 25, 2021 Filed May 27, 2021 20:55 UTC |
McCall Ronald DDirector
|
SaleCommon Stock | 5,783 | $29.55 | $170,888.23 |
DisclosureSEC source: 0000784199-21-000156 · certent-form4.xml · nonDerivative · entry 1 McCall Ronald D · CIK 0001016766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,012 F1 · price: Reflects weighted average price. Range of prices were between $29.44 to $29.77. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 06, 2021 Filed May 10, 2021 12:29 UTC |
Horton AmyVP, Chief Accounting Officer
|
Exercise / conversionCommon Stock · Derivative | 5,731 | $11.00 Strike: $11.00 | $63,041.00 |
DisclosureSEC source: 0000784199-21-000135 · certent-form4.xml · derivative · entry 3 Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,731 shares Expires 2022-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 2/19/2016 Read SEC document |
| May 06, 2021 Filed May 10, 2021 12:29 UTC |
Horton AmyVP, Chief Accounting Officer
|
SaleCommon Stock | 5,731 | $30.00 | $171,930.00 |
DisclosureSEC source: 0000784199-21-000135 · certent-form4.xml · nonDerivative · entry 2 Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,282 F1 · shares: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on Feb 26, 2021 F2 · price: Reflects the price of $30 the shares were sold. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at this price Read SEC document |
| May 06, 2021 Filed May 10, 2021 12:29 UTC |
Horton AmyVP, Chief Accounting Officer
|
Exercise / conversionCommon Stock | 5,731 | $11.00 | $63,041.00 |
DisclosureSEC source: 0000784199-21-000135 · certent-form4.xml · nonDerivative · entry 1 Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,013 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on Feb 26, 2021 Read SEC document |
| May 06, 2021 Filed May 10, 2021 12:28 UTC |
Holloway Jean FSVP, General Counsel
|
Exercise / conversionCommon Stock · Derivative | 6,618 | $10.24 Strike: $10.24 | $67,768.32 |
DisclosureSEC source: 0000784199-21-000133 · certent-form4.xml · derivative · entry 3 Holloway Jean F · CIK 0001540065 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,618 shares Expires 2023-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 2/19/2017 Read SEC document |
| May 06, 2021 Filed May 10, 2021 12:28 UTC |
Holloway Jean FSVP, General Counsel
|
SaleCommon Stock | 6,618 | $30.50 | $201,849.00 |
DisclosureSEC source: 0000784199-21-000133 · certent-form4.xml · nonDerivative · entry 2 Holloway Jean F · CIK 0001540065 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,230 F1 · shares: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adoped byt the reporting person on Feb 19, 2021 F2 · price: Reflects the price of $30.5 the shares were sold. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at this price Read SEC document |
| May 06, 2021 Filed May 10, 2021 12:28 UTC |
Holloway Jean FSVP, General Counsel
|
Exercise / conversionCommon Stock | 6,618 | $10.24 | $67,768.32 |
DisclosureSEC source: 0000784199-21-000133 · certent-form4.xml · nonDerivative · entry 1 Holloway Jean F · CIK 0001540065 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,848 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adoped byt the reporting person on Feb 19, 2021 Read SEC document |
| May 05, 2021 Filed May 7, 2021 20:18 UTC |
LEE DAVID ASHLEYExecutive VP, COO & CFO
|
Exercise / conversionCommon Stock · Derivative | 27,242 | $11.00 Strike: $11.00 | $299,662.00 |
DisclosureSEC source: 0000784199-21-000131 · certent-form4.xml · derivative · entry 4 LEE DAVID ASHLEY · CIK 0001112830 · Executive VP, COO & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 27,242 shares Expires 2022-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 2/19/2016 Read SEC document |
| May 05, 2021 Filed May 7, 2021 20:18 UTC |
LEE DAVID ASHLEYExecutive VP, COO & CFO
|
SaleCommon Stock | 27,242 | $30.00 | $817,260.00 |
DisclosureSEC source: 0000784199-21-000131 · certent-form4.xml · nonDerivative · entry 2 LEE DAVID ASHLEY · CIK 0001112830 · Executive VP, COO & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 292,685 F1 · shares: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on Feb 26, 2021 F2 · price: Reflects the price of $30 the shares were sold. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at this price Read SEC document |
| May 05, 2021 Filed May 7, 2021 20:18 UTC |
LEE DAVID ASHLEYExecutive VP, COO & CFO
|
Exercise / conversionCommon Stock | 27,242 | $11.00 | $299,662.00 |
DisclosureSEC source: 0000784199-21-000131 · certent-form4.xml · nonDerivative · entry 1 LEE DAVID ASHLEY · CIK 0001112830 · Executive VP, COO & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 319,927 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on Feb 26, 2021 Read SEC document |
| May 05, 2021 Filed May 7, 2021 20:17 UTC |
Horton AmyVP, Chief Accounting Officer
|
Exercise / conversionCommon Stock · Derivative | 5,186 | $11.00 Strike: $11.00 | $57,046.00 |
DisclosureSEC source: 0000784199-21-000129 · certent-form4.xml · derivative · entry 3 Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,186 shares Expires 2022-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 2/19/2016 Read SEC document |
| May 05, 2021 Filed May 7, 2021 20:17 UTC |
Horton AmyVP, Chief Accounting Officer
|
SaleCommon Stock | 5,186 | $30.00 | $155,580.00 |
DisclosureSEC source: 0000784199-21-000129 · certent-form4.xml · nonDerivative · entry 2 Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,282 F1 · shares: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on Feb 26, 2021 F2 · price: Reflects the price of $30 the shares were sold. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at this price Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.